Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Corixa invests in, works with ImmGenics to develop high-potency monoclonal antibodies

Nov. 9, 1998

Dutch research group focuses attention on adenosine A3 receptor ligands

Nov. 5, 1998

Step taken toward European protection for AltaRex's fundamental technology platform

Nov. 5, 1998

GenVec receives expanded patent coverage in field of gene therapy

Nov. 4, 1998

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Nov. 4, 1998

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

ArQule, Roche Bioscience amend R&D agreement

Nov. 3, 1998

Targeted Genetics receives patent coverage for cellular therapy platform

Nov. 2, 1998

Senetek licenses autoinjectable drug delivery system to ICN

Oct. 29, 1998

IDEA licenses drug delivery technology to Procter & Gamble

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...